Table 1.
Phenotype | Gene | Inheritance |
---|---|---|
Familial adenomatous polyposis | APC | AD |
| ||
Multiple endocrine neoplasia type 1, familial medullary thyroid cancer | RET | AD |
| ||
Hereditary breast and/or ovarian cancer | BRCA1, BRCA2, PALB2 | AD |
| ||
Hereditary paraganglioma-phaeochromocytoma syndrome | SDHD, SDHA, SDHAF2, SDHC, SDHB, MAX, TMEM127 | AD |
| ||
Juvenile polyposis syndrome | BMPR1A, SMAD4 | AD |
| ||
Li-Fraumeni syndrome | TP53 | AD |
| ||
Lynch syndrome | MLH1, MSH2, MSH6, PMS2, EPCAM | AD |
| ||
Multiple endocrine neoplasia type 1 | MEN1 | AD |
| ||
MUTYH-associated polyposis | MUTYH | AR |
| ||
Neurofibromatosis type 2 | NF2 | AD |
| ||
Peutz-Jeghers syndrome | STK11 | AD |
| ||
PTEN hamartoma tumour syndrome | PTEN | AD |
| ||
Retinoblastoma | RB1 | AD |
| ||
Tuberous sclerosis syndrome | TSC1, TSC2 | AD |
| ||
Von Hippel-Lindau syndrome | VHL | AD |
| ||
WT1-related Wilms tumour | WT1 | AD |
AD: autosomal dominant, AR: autosomal recessive